Nuance to acquire QuadraMed HIM business

Nuance Communications announced Thursday that it will acquire Quantim, the health information management (HIM) business of Reston, Va.-based QuadraMed.

Together – and working alongside other vendors, such as EHR developers – the two companies will work to help clients transition to ICD-10, Nuance officials say.

The integration of Nuance’s clinical language understanding (CLU) technology with Quantim’s computer-assisted coding (CAC) tools is meant spur a more efficient workflow for HIM professionals and speed reimbursement; it's hoped that such an automated, integrated coding solution will also improve clinician productivity during the transition to ICD-10 and improve the quality of care.

"We are excited to welcome the Quantim customers and staff to the Nuance team, and look forward to working together to create an innovative solution to help providers address critical productivity and reimbursement challenges associated with clinical documentation and coding," said Janet Dillione, executive vice president and general manager, Nuance Healthcare.

Nuance plans to offer CLU-powered CAC solutions within Quantim's Web-based platform to support a smoother ICD-10 switchover. The technology will:

  • Bridge the capture of clinical information with natural language processing-driven coding and compliance, with an aim toward shortening the time between patient care and appropriate reimbursement;
  • Streamline clinical documentation improvement (CDI) and support CDI and coding specialists within a single platform to decrease the time spent on physician follow-up when additional specific patient details are needed to properly code the care provided; and
  • Integrate Nuance’s CLU technology to aid coders by providing them with automated prompts that can assist them in ensuring compliance and adjusting to the increased ICD-10 code base.

“The acquisition of QuadraMed’s HIM business is a natural extension of Nuance’s strategy to transform the clinical documentation and revenue cycle processes,” said Duncan James, chief executive officer, QuadraMed. “We are enthusiastic about the opportunity this acquisition provides for our Quantim clients and employees who will benefit from the value of Nuance’s vision and innovative technology.”

[See also: Nuance buys Webmedx]